Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1992 3
1993 4
1994 1
1996 3
1998 1
1999 2
2001 1
2002 1
2003 1
2004 2
2005 1
2006 7
2008 4
2009 5
2010 5
2011 7
2012 8
2013 8
2014 7
2015 14
2016 10
2017 11
2018 8
2019 10
2020 4
2021 13
2022 7
2023 5
2024 10
2025 10
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean n wakil (326 results)?
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E; PIONEER-HF Investigators. Velazquez EJ, et al. N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11. N Engl J Med. 2019. PMID: 30415601 Clinical Trial.
The primary efficacy outcome was the time-averaged proportional change in the N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration from baseline through weeks 4 and 8. ...
The primary efficacy outcome was the time-averaged proportional change in the N-terminal pro-B-type natriuretic peptide (NT-proBNP) c …
An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers.
Kandinov B, Soens M, Huang W, Llapur C, Ensz D, Essink B, Fierro C, Vakil J, Pucci A, Guo J, Rudden S, Hall K, Hicks B, Schaefers K, Zhou H, Ma C, Zheng L, Avanesov A, Park Y, Du E, Miller J, Ananworanich J, Nachbagauer R. Kandinov B, et al. Hum Vaccin Immunother. 2025 Dec;21(1):2484088. doi: 10.1080/21645515.2025.2484088. Epub 2025 Apr 2. Hum Vaccin Immunother. 2025. PMID: 40174609 Free PMC article. Clinical Trial.
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S. WHO Solidarity Trial Consortium, et al. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2. N Engl J Med. 2021. PMID: 33264556 Free PMC article. Clinical Trial.
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM; PRESERVE Trial Group. Weisbord SD, et al. N Engl J Med. 2018 Feb 15;378(7):603-614. doi: 10.1056/NEJMoa1710933. Epub 2017 Nov 12. N Engl J Med. 2018. PMID: 29130810 Free article. Clinical Trial.
PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
Fuller G, Bolus R, Whitman C, Talley J, Erder MH, Joseph A, Silberg DG, Spiegel B. Fuller G, et al. Dig Dis Sci. 2017 Mar;62(3):593-606. doi: 10.1007/s10620-016-4440-7. Epub 2017 Jan 23. Dig Dis Sci. 2017. PMID: 28116591
BACKGROUND: Most patients with gastroesophageal reflux disease (GERD) experience relief following treatment with proton pump inhibitors (PPIs) (Vakil et al. in Am J Gastroenterol 101:1900-1920, 2006; Everhart and Ruhl in Gastroenterology 136:376-386, 2009). ...RESULTS: Dur …
BACKGROUND: Most patients with gastroesophageal reflux disease (GERD) experience relief following treatment with proton pump inhibitors (PPI …
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries.
NIHR Global Health Research Unit on Global Surgery. NIHR Global Health Research Unit on Global Surgery. Lancet Glob Health. 2024 Jul;12(7):e1094-e1103. doi: 10.1016/S2214-109X(24)00142-6. Epub 2024 May 23. Lancet Glob Health. 2024. PMID: 38797188 Free article.
In patients eligible for day-case surgery (n=12 658), day-case rates were low and variable (50.0%, 38.0%, 42.1%, 44.5%). Complications occurred in 2415 (13.4%) of 18 018 patients and were more common after emergency surgery (adjusted odds ratio 2.06, 95% CI 1.72-2.46) and …
In patients eligible for day-case surgery (n=12 658), day-case rates were low and variable (50.0%, 38.0%, 42.1%, 44.5%). Complication …
Enteroscopy. Outcomes.
Huilgol V, Harris MS, Vakil N. Huilgol V, et al. Gastrointest Endosc Clin N Am. 1996 Oct;6(4):811-7. Gastrointest Endosc Clin N Am. 1996. PMID: 8899411 Review.
155 results